Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides

Journal of Antimicrobial Chemotherapy

Volumn 52, Issue 4, 2003, Pages 724-726

  Giacometti, Andrea ^a,c   Ghiselli, Roberto ^b   Cirioni, Oscar ^a   Mocchegiani, Federico ^b   Orlando, Fiorenza ^b   Del Prete, Maria Simona ^a   D'Amato, Giuseppina ^a   Silvestri, Carmela ^a   Saba, Vittorio ^b   Scalise, Giorgio ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b INRCA   (Italy)

^c Ospedale Regionale Torrette   (Italy)

Author keywords

Antibiotic prophylaxis; GISE; Oxazolidinones; Vascular surgery

Indexed keywords

ANTIBIOTIC AGENT; LEVOFLOXACIN; LINEZOLID; METICILLIN; OFLOXACIN; OXAZOLIDINONE DERIVATIVE; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BLOOD VESSEL PROSTHESIS; CONTROLLED STUDY; DACRON VASCULAR PROSTHESIS; DEVICE REMOVAL; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; GENDER; GRAFT INFECTION; INOCULATION; MULTIDRUG RESISTANCE; NONHUMAN; PENICILLIN RESISTANCE; PERIOPERATIVE PERIOD; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; STAPHYLOCOCCUS EPIDERMIDIS; STATISTICAL SIGNIFICANCE; SUBCUTANEOUS TISSUE; TIME; TREATMENT OUTCOME;

ACETAMIDES; ANIMALS; ANTIBIOTIC PROPHYLAXIS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; GLYCOPEPTIDES; GRAFT REJECTION; MALE; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; OXAZOLIDINONES; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN;

EID: 0141997689     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg396     Document Type: Article

References (10)

1. Raad, I., Alrahwan, A. & Rolston, K. (1998). Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clinical Infectious Diseases 26, 1182-7.
2. Henke, P. K., Bergamini, T. M., Rose, S. M. et al. (1998). Current opinion in prosthetic vascular graft infection. American Surgeon 64, 39-45.
3. Von Eiff, C., Heilmann, C. & Peters, G. (1999). New aspects in the molecular basis of polymer-associated infections due to staphylococci. European Journal of Clinical Microbiology and Infectious Diseases 18, 843-6.
4. Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999). Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-22.
5. Paladino, J. A. (2002). Linezolid: an oxazolidinone antimicrobial agent. American Journal of Health-System Pharmacy 59, 2413-25.
6. Chambers, H. F., Xiang Liu, Q., Liuxin Chow, L. et al. (1999). Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 43, 2742-6.
7. Jarvis, W. R. (1998). Epidemiology, appropriateness, and cost of vancomycin use. Clinical Infectious Diseases 26, 1200-3.
8. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically: Approved Standard M7-A4. NCCLS, Wayne, PA, USA.
9. National Committee for Clinical Laboratory Standards. (1997). Performance Standards for Antimicrobial Disk Susceptibility Test Approved Standard M2-A6. NCCLS, Wayne, PA, USA.
10. Gonzales, R. D., Schreckenberger, P. C., Graham, M. B. et al. (2001). Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357, 1179.